PD-L1 prevalence in advanced urothelial carcinoma by demographic and clinical characteristics

被引：0
|
作者：
Powles, T. B. [1 ]
van der Heijden, M. S. [2 ]
Balar, A. V. [3 ]
O'Donnell, P. [4 ]
Massard, C. [5 ]
Walker, J. [6 ]
Gupta, A. [7 ]
Angra, N. [7 ]
Cairns, J. [8 ]
Turriziani, B. [6 ]
Rebelatto, M. C. [7 ]
Scott, M. [6 ]
Wildsmith, S. [6 ]
机构：
[1] Queen Mary Univ London, Barts Canc Inst, Ctr Expt Canc Med, London, England
[2] Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands
[3] NYU, Dept Med, Perlmutter Canc Ctr, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA
[4] Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA
[5] Gustave Roussy Canc Campus, DITEP, Villejuif, France
[6] AstraZeneca, Oncol R&D, Cambridge, England
[7] AstraZeneca, Oncol R&D, Gaithersburg, MD USA
[8] AstraZeneca, Stat, Cambridge, England
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.498
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13P
引用
收藏
页码：S1421 / S1421
页数：1
相关论文
共 50 条
  • [1] PD-L1 prevalence in advanced urothelial carcinoma by demographic and clinical characteristics
    Pedersen, Ward A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1421 - S1422
  • [2] PD-L1 blockade for urothelial carcinoma
    Kang, Josephine
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2017, 6 (07):
  • [3] PD-L1 Antibody Comparison in Urothelial Carcinoma
    Rijnders, Maud
    van der Veldt, Astrid A. M.
    Zuiverloon, Tahlita C. M.
    Grunberg, Katrien
    Thunnissen, Erik
    de Wit, Ronald
    van Leenders, Geert J. L. H.
    EUROPEAN UROLOGY, 2019, 75 (03) : 538 - 540
  • [4] A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
    Nassar, Amin H.
    Mouw, Kent W.
    Jegede, Opeyemi
    Shinagare, Atul B.
    Kim, Jaegil
    Liu, Chia-Jen
    Pomerantz, Mark
    Harshman, Lauren C.
    Van Allen, Eliezer M.
    Wei, Xiao X.
    McGregor, Bradley
    Choudhury, Atish D.
    Preston, Mark A.
    Dong, Fei
    Signoretti, Sabina
    Lindeman, Neal I.
    Bellmunt, Joaquim
    Choueiri, Toni K.
    Sonpavde, Guru
    Kwiatkowski, David J.
    BRITISH JOURNAL OF CANCER, 2020, 122 (04) : 555 - 563
  • [5] A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
    Amin H. Nassar
    Kent W. Mouw
    Opeyemi Jegede
    Atul B. Shinagare
    Jaegil Kim
    Chia-Jen Liu
    Mark Pomerantz
    Lauren C. Harshman
    Eliezer M. Van Allen
    Xiao X. Wei
    Bradley McGregor
    Atish D. Choudhury
    Mark A. Preston
    Fei Dong
    Sabina Signoretti
    Neal I. Lindeman
    Joaquim Bellmunt
    Toni K. Choueiri
    Guru Sonpavde
    David J. Kwiatkowski
    British Journal of Cancer, 2020, 122 : 555 - 563
  • [6] Prevalence of PD-L1 expression in first-line (1L) locally advanced/unresectable or metastatic urothelial carcinoma (UC).
    Grivas, Petros
    Morgans, Alicia K.
    Lotan, Yair
    Gregg, Jeffrey P.
    Geynisman, Daniel M.
    Friedlander, Terence W.
    Agarwal, Piyush K.
    Tesic-Schnell, Marija
    Bernstein, Andrew
    Makari, Doris
    Meeks, Joshua J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [7] Prevalence of PD-L1 expression in 1st-line (1L) locally advanced/unresectable or metastatic urothelial carcinoma (UC)
    Grivas, Petros
    Morgans, Alicia K.
    Lotan, Yair
    Gregg, Jeffrey
    Geynisman, Daniel
    Friedlander, Terence
    Agarwal, Piyush K.
    Tesic-Schnell, Marija
    Bernstein, Andrew
    Makari, Doris
    Meeks, Joshua J.
    CANCER RESEARCH, 2019, 79 (13)
  • [8] PD-1/PD-L1 Combinations in Advanced Urothelial Cancer: Rationale and Current Clinical Trials
    Hsu, Miles M.
    Balar, Arjun
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : E618 - E626
  • [9] Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade
    Hamidi, Habib
    Senbabaoglu, Yasin
    Beig, Niha
    Roels, Juliette
    Manuel, Cyrus
    Guan, Xiangnan
    Koeppen, Hartmut
    Assaf, Zoe June
    Nabet, Barzin Y.
    Waddell, Adrian
    Yuen, Kobe
    Maund, Sophia
    Sokol, Ethan
    Giltnane, Jennifer M.
    Schedlbauer, Amber
    Fuentes, Eloisa
    Cowan, James D.
    Kadel, Edward E.
    Degaonkar, Viraj
    Andreev-Drakhlin, Alexander
    Williams, Patrick
    Carter, Corey
    Gupta, Suyasha
    Steinberg, Elizabeth
    Loriot, Yohann
    Bellmunt, Joaquim
    Grivas, Petros
    Rosenberg, Jonathan
    van der Heijden, Michiel S.
    Galsky, Matthew D.
    Powles, Thomas
    Mariathasan, Sanjeev
    Banchereau, Romain
    CANCER CELL, 2024, 42 (12)
  • [10] The expression and clinical significance of PD-L1 in patients with upper tract urothelial carcinoma
    Sheng, Xinan
    He, Zhisong
    Kong, Yan
    Chi, Zhihong
    Si, Lu
    Cui, Chuanliang
    Tang, Bixia
    Mao, Li Li
    Wang, Xuan
    Lian, Bin
    Yan, Xieqiao
    Li, Si Ming
    Dai, Jie
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345